A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 44,500 shares of OVID stock, worth $55,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,500
Previous 141,200 68.48%
Holding current value
$55,180
Previous $108,000 51.85%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.75 - $1.3 $72,525 - $125,710
-96,700 Reduced 68.48%
44,500 $52,000
Q2 2024

Aug 09, 2024

SELL
$0.7 - $3.34 $10,920 - $52,104
-15,600 Reduced 9.95%
141,200 $108,000
Q1 2024

May 13, 2024

BUY
$2.72 - $4.04 $287,232 - $426,624
105,600 Added 206.25%
156,800 $478,000
Q4 2023

Feb 13, 2024

SELL
$2.98 - $3.78 $88,208 - $111,888
-29,600 Reduced 36.63%
51,200 $165,000
Q3 2023

Nov 14, 2023

SELL
$3.23 - $3.97 $109,497 - $134,583
-33,900 Reduced 29.56%
80,800 $310,000
Q2 2023

Aug 11, 2023

SELL
$2.53 - $3.89 $14,926 - $22,951
-5,900 Reduced 4.89%
114,700 $376,000
Q1 2023

May 12, 2023

BUY
$1.88 - $2.85 $1,504 - $2,280
800 Added 0.67%
120,600 $311,000
Q4 2022

Feb 13, 2023

BUY
$1.43 - $1.89 $1,430 - $1,890
1,000 Added 0.84%
119,800 $223,000
Q3 2022

Nov 14, 2022

SELL
$1.84 - $2.26 $9,200 - $11,299
-5,000 Reduced 4.04%
118,800 $219,000
Q2 2022

Aug 12, 2022

BUY
$1.69 - $3.31 $65,910 - $129,090
39,000 Added 45.99%
123,800 $266,000
Q1 2022

May 13, 2022

BUY
$2.65 - $3.49 $69,430 - $91,438
26,200 Added 44.71%
84,800 $266,000
Q4 2021

Feb 11, 2022

BUY
$3.13 - $3.73 $75,433 - $89,893
24,100 Added 69.86%
58,600 $188,000
Q3 2021

Nov 12, 2021

BUY
$3.31 - $4.04 $114,195 - $139,380
34,500 New
34,500 $116,000
Q1 2021

May 13, 2021

SELL
$2.42 - $4.47 $1.72 Million - $3.18 Million
-710,507 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$2.28 - $6.84 $1.62 Million - $4.86 Million
710,507 New
710,507 $1.64 Million
Q3 2020

Nov 13, 2020

SELL
$5.39 - $8.24 $3.36 Million - $5.14 Million
-624,109 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$2.67 - $7.91 $610,719 - $1.81 Million
-228,734 Reduced 26.82%
624,109 $4.6 Million
Q1 2020

May 14, 2020

SELL
$2.03 - $4.35 $470,687 - $1.01 Million
-231,866 Reduced 21.38%
852,843 $2.54 Million
Q4 2019

Feb 13, 2020

BUY
$2.08 - $5.06 $1.04 Million - $2.52 Million
497,984 Added 84.88%
1,084,709 $4.5 Million
Q3 2019

Nov 13, 2019

BUY
$1.76 - $3.51 $202,604 - $404,057
115,116 Added 24.41%
586,725 $1.9 Million
Q2 2019

Aug 12, 2019

BUY
$1.59 - $2.14 $172,343 - $231,958
108,392 Added 29.84%
471,609 $872,000
Q1 2019

May 14, 2019

BUY
$1.77 - $3.56 $545,367 - $1.1 Million
308,117 Added 559.2%
363,217 $643,000
Q4 2018

Feb 13, 2019

BUY
$2.42 - $6.6 $133,342 - $363,660
55,100 New
55,100 $133,000

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $87.3M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.